{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:25:09Z","timestamp":1790691909201,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,8,22]],"date-time":"2015-08-22T00:00:00Z","timestamp":1440201600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["30871433"],"award-info":[{"award-number":["30871433"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31071305"],"award-info":[{"award-number":["31071305"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aesth Plast Surg"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s00266-015-0542-4","type":"journal-article","created":{"date-parts":[[2015,8,21]],"date-time":"2015-08-21T12:13:16Z","timestamp":1440159196000},"page":"818-825","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Analysis of Characteristics Similar to Autoimmune Disease in Keloid Patients"],"prefix":"10.1007","volume":"39","author":[{"given":"Hu","family":"Jiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jincai","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinglong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianlei","family":"Zong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,22]]},"reference":[{"key":"542_CR1","first-page":"283","volume":"24","author":"GM Bran","year":"2009","unstructured":"Bran GM, Goessler UR, Hormann K, Riedel F, Sadick H (2009) Keloids: current concepts of pathogenesis (review). Int J Mol Med 24:283\u2013293","journal-title":"Int J Mol Med"},{"key":"542_CR2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/bmj.326.7380.88","volume":"326","author":"A Bayat","year":"2003","unstructured":"Bayat A, McGrouther DA, Ferguson MW (2003) Skin scarring. BMJ 326:88\u201392","journal-title":"BMJ"},{"key":"542_CR3","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.bjps.2008.03.020","volume":"61","author":"BC Brown","year":"2008","unstructured":"Brown BC, McKenna SP, Siddhi K, McGrouther DA, Bayat A (2008) The hidden cost of skin scars: quality of life after skin scarring. J Plast Reconstr Aesthet Surg 61:1049\u20131058","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"542_CR4","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1365-2133.2012.11190.x","volume":"167","author":"R Bagabir","year":"2012","unstructured":"Bagabir R, Byers RJ, Chaudhry IH, Muller W, Paus R, Bayat A (2012) Site-specific immunophenotyping of keloid disease demonstrates immune upregulation and the presence of lymphoid aggregates. Br J Dermatol 167:1053\u20131066","journal-title":"Br J Dermatol"},{"key":"542_CR5","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1524-475X.2009.00533.x","volume":"17","author":"PD Verhaegen","year":"2009","unstructured":"Verhaegen PD, van Zuijlen PP, Pennings NM, van Marle J, Niessen FB, van der Horst CM, Middelkoop E (2009) Differences in collagen architecture between keloid, hypertrophic scar, normotrophic scar, and normal skin: an objective histopathological analysis. Wound Repair Regen 17:649\u2013656","journal-title":"Wound Repair Regen"},{"key":"542_CR6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3181\/0707-MR-190","volume":"233","author":"T Kisseleva","year":"2008","unstructured":"Kisseleva T, Brenner DA (2008) Mechanisms of fibrogenesis. Exp Biol Med (Maywood) 233:109\u2013122","journal-title":"Exp Biol Med (Maywood)"},{"key":"542_CR7","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/sj.jid.5700811","volume":"127","author":"BM Stramer","year":"2007","unstructured":"Stramer BM, Mori R, Martin P (2007) The inflammation-fibrosis link? A Jekyll and Hyde role for blood cells during wound repair. J Invest Dermatol 127:1009\u20131017","journal-title":"J Invest Dermatol"},{"key":"542_CR8","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1365-2559.2010.03717.x","volume":"57","author":"S Detlefsen","year":"2010","unstructured":"Detlefsen S, Brasen JH, Zamboni G, Capelli P, Kloppel G (2010) Deposition of complement C3c, immunoglobulin (Ig)G4 and IgG at the basement membrane of pancreatic ducts and acini in autoimmune pancreatitis. Histopathology 57:825\u2013835","journal-title":"Histopathology"},{"key":"542_CR9","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.4065\/70.11.1068","volume":"70","author":"LS Peterson","year":"1995","unstructured":"Peterson LS, Nelson AM, Su WP (1995) Classification of morphea (localized scleroderma). Mayo Clin Proc 70:1068\u20131076","journal-title":"Mayo Clin Proc"},{"key":"542_CR10","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/ncprheum0115","volume":"2","author":"CP Denton","year":"2006","unstructured":"Denton CP, Black CM, Abraham DJ (2006) Mechanisms and consequences of fibrosis in systemic sclerosis. Nat Clin Pract Rheumatol 2:134\u2013144","journal-title":"Nat Clin Pract Rheumatol"},{"key":"542_CR11","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.jamcollsurg.2007.12.001","volume":"206","author":"PD Butler","year":"2008","unstructured":"Butler PD, Longaker MT, Yang GP (2008) Current progress in keloid research and treatment. J Am Coll Surg 206:731\u2013741","journal-title":"J Am Coll Surg"},{"key":"542_CR12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1756-185X.2009.01444.x","volume":"13","author":"AP Huo","year":"2010","unstructured":"Huo AP, Lin KC, Chou CT (2010) Predictive and prognostic value of antinuclear antibodies and rheumatoid factor in primary Sjogren\u2019s syndrome. Int J Rheum Dis 13:39\u201347","journal-title":"Int J Rheum Dis"},{"key":"542_CR13","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1191\/0961203305lu2240rr","volume":"14","author":"L Rycke De","year":"2005","unstructured":"De Rycke L, Baeten D, Kruithof E, Van den Bosch F, Veys EM, De Keyser F (2005) The effect of TNFalpha blockade on the antinuclear antibody profile in patients with chronic arthritis: biological and clinical implications. Lupus 14:931\u2013937","journal-title":"Lupus"},{"key":"542_CR14","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/RHU.0b013e3181bb971b","volume":"15","author":"GG Marin","year":"2009","unstructured":"Marin GG, Cardiel MH, Cornejo H, Viveros ME (2009) Prevalence of antinuclear antibodies in 3 groups of healthy individuals: blood donors, hospital personnel, and relatives of patients with autoimmune diseases. J Clin Rheumatol 15:325\u2013329","journal-title":"J Clin Rheumatol"},{"key":"542_CR15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/ar3282","volume":"13","author":"DS Pisetsky","year":"2011","unstructured":"Pisetsky DS (2011) Antinuclear antibodies in healthy people: the tip of autoimmunity\u2019s iceberg? Arthritis Res Ther 13:109","journal-title":"Arthritis Res Ther"},{"key":"542_CR16","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1161\/CIRCULATIONAHA.108.771170","volume":"120","author":"TN Mayadas","year":"2009","unstructured":"Mayadas TN, Tsokos GC, Tsuboi N (2009) Mechanisms of immune complex-mediated neutrophil recruitment and tissue injury. Circulation 120:2012\u20132024","journal-title":"Circulation"},{"key":"542_CR17","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2340\/00015555-0975","volume":"90","author":"SM McCarty","year":"2010","unstructured":"McCarty SM, Syed F, Bayat A (2010) Influence of the human leukocyte antigen complex on the development of cutaneous fibrosis: an immunogenetic perspective. Acta Derm Venereol 90:563\u2013574","journal-title":"Acta Derm Venereol"},{"key":"542_CR18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00403-009-0952-8","volume":"301","author":"O Seifert","year":"2009","unstructured":"Seifert O, Mrowietz U (2009) Keloid scarring: bench and bedside. Arch Dermatol Res 301:259\u2013272","journal-title":"Arch Dermatol Res"},{"key":"542_CR19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/jso.2930380106","volume":"38","author":"AA Kazeem","year":"1988","unstructured":"Kazeem AA (1988) The immunological aspects of keloid tumor formation. J Surg Oncol 38:16\u201318","journal-title":"J Surg Oncol"},{"key":"542_CR20","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/00006534-198403000-00020","volume":"73","author":"EF Bloch","year":"1984","unstructured":"Bloch EF, Hall MG Jr, Denson MJ, Slay-Solomon V (1984) General immune reactivity in keloid patients. Plast Reconstr Surg 73:448\u2013451","journal-title":"Plast Reconstr Surg"},{"key":"542_CR21","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/00006534-197905000-00013","volume":"63","author":"IK Cohen","year":"1979","unstructured":"Cohen IK, McCoy BJ, Mohanakumar T, Diegelmann RF (1979) Immunoglobulin, complement, and histocompatibility antigen studies in keloid patients. Plast Reconstr Surg 63:689\u2013695","journal-title":"Plast Reconstr Surg"},{"key":"542_CR22","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/00006534-198306000-00015","volume":"71","author":"CW Kischer","year":"1983","unstructured":"Kischer CW, Shetlar MR, Shetlar CL, Chvapil M (1983) Immunoglobulins in hypertrophic scars and keloids. Plast Reconstr Surg 71:821\u2013825","journal-title":"Plast Reconstr Surg"},{"key":"542_CR23","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0007-1226(79)90037-7","volume":"32","author":"KI Yagi","year":"1979","unstructured":"Yagi KI, Dafalla AA, Osman AA (1979) Does an immune reaction to sebum in wounds cause keloid scars? Beneficial effect of desensitisation. Br J Plast Surg 32:223\u2013225","journal-title":"Br J Plast Surg"},{"key":"542_CR24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF01570634","volume":"6","author":"AM Janssen de Limpens","year":"1982","unstructured":"Janssen de Limpens AM, Cormane RH (1982) Keloids and hypertrophic scars\u2013immunological aspects. Aesthetic Plast Surg 6:149\u2013152","journal-title":"Aesthetic Plast Surg"},{"key":"542_CR25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev.bi.62.070193.001445","volume":"62","author":"G Dreyfuss","year":"1993","unstructured":"Dreyfuss G, Matunis MJ, Pinol-Roma S, Burd CG (1993) hnRNP proteins and the biogenesis of mRNA. Annu Rev Biochem 62:289\u2013321","journal-title":"Annu Rev Biochem"},{"key":"542_CR26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/08916930400022590","volume":"38","author":"R Caporali","year":"2005","unstructured":"Caporali R, Bugatti S, Bruschi E, Cavagna L, Montecucco C (2005) Autoantibodies to heterogeneous nuclear ribonucleoproteins. Autoimmunity 38:25\u201332","journal-title":"Autoimmunity"},{"key":"542_CR27","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/0014-5793(88)80714-2","volume":"231","author":"A Dangli","year":"1988","unstructured":"Dangli A, Guialis A, Vretou E, Sekeris CE (1988) Autoantibodies to the core proteins of hnRNPs. FEBS Lett 231:118\u2013124","journal-title":"FEBS Lett"},{"key":"542_CR28","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/anr.1780321204","volume":"32","author":"W Hassfeld","year":"1989","unstructured":"Hassfeld W, Steiner G, Hartmuth K, Kolarz G, Scherak O, Graninger W, Thumb N, Smolen JS (1989) Demonstration of a new antinuclear antibody (anti-RA33) that is highly specific for rheumatoid arthritis. Arthritis Rheum 32:1515\u20131520","journal-title":"Arthritis Rheum"},{"key":"542_CR29","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/08916930701352357","volume":"40","author":"S Siapka","year":"2007","unstructured":"Siapka S, Patrinou-Georgoula M, Vlachoyiannopoulos PG, Guialis A (2007) Multiple specificities of autoantibodies against hnRNP A\/B proteins in systemic rheumatic diseases and hnRNP L as an associated novel autoantigen. Autoimmunity 40:223\u2013233","journal-title":"Autoimmunity"},{"key":"542_CR30","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/096120339200100405","volume":"1","author":"R Neri","year":"1992","unstructured":"Neri R, Tavoni A, Cristofani R, Levanti C, Sodini G, d\u2019Ascanio A, Vitali C, Ferri C, Bombardieri S (1992) Antinuclear antibody profile in Italian patients with connective tissue diseases. Lupus 1:221\u2013227","journal-title":"Lupus"},{"key":"542_CR31","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s10067-010-1515-2","volume":"29","author":"E Guevara-Gutierrez","year":"2010","unstructured":"Guevara-Gutierrez E, Yinh-Lao J, Garcia-Gutierrez P, Tlacuilo-Parra A (2010) Frequency of antinuclear antibodies in mestizo Mexican children with morphea. Clin Rheumatol 29:1055\u20131059","journal-title":"Clin Rheumatol"},{"key":"542_CR32","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1468-3083.2004.01132.x","volume":"19","author":"K Preisz","year":"2005","unstructured":"Preisz K, Sardy M, Horvath A, Karpati S (2005) Immunoglobulin, complement and epidermal transglutaminase deposition in the cutaneous vessels in dermatitis herpetiformis. J Eur Acad Dermatol Venereol 19:74\u201379","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"542_CR33","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/PAI.0b013e3181efa2ef","volume":"19","author":"SA Shaker","year":"2011","unstructured":"Shaker SA, Ayuob NN, Hajrah NH (2011) Cell talk: a phenomenon observed in the keloid scar by immunohistochemical study. Appl Immunohistochem Mol Morphol 19:153\u2013159","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"542_CR34","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1440-1827.2007.02105.x","volume":"57","author":"M Onodera","year":"2007","unstructured":"Onodera M, Ueno M, Ito O, Suzuki S, Igawa HH, Sakamoto H (2007) Factor XIIIa-positive dermal dendritic cells in keloids and hypertrophic and mature scars. Pathol Int 57:337\u2013342","journal-title":"Pathol Int"},{"key":"542_CR35","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1054\/bjps.2001.3638","volume":"54","author":"DE Boyce","year":"2001","unstructured":"Boyce DE, Ciampolini J, Ruge F, Murison MS, Harding KG (2001) Inflammatory-cell subpopulations in keloid scars. Br J Plast Surg 54:511\u2013516","journal-title":"Br J Plast Surg"},{"key":"542_CR36","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.imlet.2005.10.023","volume":"103","author":"PL Lim","year":"2006","unstructured":"Lim PL, Zouali M (2006) Pathogenic autoantibodies: emerging insights into tissue injury. Immunol Lett 103:17\u201326","journal-title":"Immunol Lett"},{"key":"542_CR37","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/ar73","volume":"2","author":"C Benoist","year":"2000","unstructured":"Benoist C, Mathis D (2000) A revival of the B cell paradigm for rheumatoid arthritis pathogenesis? Arthritis Res 2:90\u201394","journal-title":"Arthritis Res"},{"issue":"Suppl 1","key":"542_CR38","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/ar3908","volume":"15","author":"MJ Leandro","year":"2013","unstructured":"Leandro MJ (2013) B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies. Arthritis Res Ther 15(Suppl 1):S3","journal-title":"Arthritis Res Ther"},{"issue":"Suppl 1","key":"542_CR39","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/ar3906","volume":"15","author":"S Bluml","year":"2013","unstructured":"Bluml S, McKeever K, Ettinger R, Smolen J, Herbst R (2013) B-cell targeted therapeutics in clinical development. Arthritis Res Ther 15(Suppl 1):S4","journal-title":"Arthritis Res Ther"}],"container-title":["Aesthetic Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00266-015-0542-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00266-015-0542-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00266-015-0542-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T13:07:46Z","timestamp":1558703266000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00266-015-0542-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,22]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["542"],"URL":"https:\/\/doi.org\/10.1007\/s00266-015-0542-4","relation":{},"ISSN":["0364-216X","1432-5241"],"issn-type":[{"value":"0364-216X","type":"print"},{"value":"1432-5241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,22]]}}}